TBXT and cancer: Immune-related enrichment results included immunoglobulin mediated immune response, immunoglobulin receptor binding, B cell receptor signaling pathway, leukocyte transendothelial migration, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, and PD-1 checkpoint pathway in cancer.